Fig. 1From: Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors—retrospective studyUnivariate and multivariate analyses. Univariate and multivariate analyses for adenocarcinoma and non-adenocarcinoma regarding the following items: KPS, age, extracranial metastases, number of brain metastasis, gene mutation, PD-L1 expression, whole brain radiotherapy, hypo-fractionated stereotactic radiosurgery, surgery, chemotherapy and use of a tyrosine-kinase inhibitorBack to article page